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d SC-islets show improved insulin and IAPP releasewith time in
transplanted diabetic mice
d SC-islet cells undergo drastic transcriptome changes after
6 months in vivo
d Grafted SC-b cells mature and express MAFA, CHGB,
G6PC2, and FAM159B in vivo
d Differentially expressed genes upon transplantation









Augsornworawat et al. demonstrate that
in vitro human stem-cell-derived islets
have immature transcriptome profiles
when compared to native human islets.
After transplantation, immature SC-islet
cells undergo drastic changes in
transcriptome and acquire mature gene
expression. Grafted SC-b cells express
mature b cell genes, including MAFA and
G6PC2, resembling native human islets.
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Human pluripotent stem cells differentiated to insulin-secreting b cells (SC-b cells) in islet organoids could
provide an unlimited cell source for diabetes cell replacement therapy. However, current SC-b cells gener-
ated in vitro are transcriptionally and functionally immature compared to native adult b cells. Here, we use
single-cell transcriptomic profiling to catalog changes that occur in transplanted SC-b cells. We find that
transplanted SC-b cells exhibit drastic transcriptional changes and mature to more closely resemble adult
b cells. Insulin and IAPP protein secretions increase upon transplantation, along with expression of matura-
tion genes lacking with differentiation in vitro, including INS,MAFA, CHGB, and G6PC2. Other differentiated
cell types, such as SC-a and SC-enterochromaffin (SC-EC) cells, also exhibit large transcriptional changes.
This study provides a comprehensive resource for understanding human islet cell maturation and provides
important insights into maturation of SC-b cells and other SC-islet cell types to enable future differentiation
strategy improvements.
INTRODUCTION
Diabetes is a global disease caused by death or dysfunction of
pancreatic insulin (INS)-producing b cells. Current conventional
therapeutic strategies, such as exogenous INS treatment, are
insufficient in recapitulating the role of healthy endogenous b
cells for many patients (Atkinson et al., 2014). Transplantation
of replacement human islets (HIs) is a promising alternative
(Latres et al., 2019;Shapiro et al., 2006, 2000).However, this ther-
apy faces the challenge of limited availability from cadaveric do-
nors. This is compounded by the need of multiple donors to treat
one diabetic patient in most cases. Human pluripotent stem cells
(hPSCs) differentiated into functional islets (SC-islets) containing
b cells (SC-b cells) would provide a renewable cell source for cell
replacement therapy (Aguayo-Mazzucato and Bonner-Weir,
2010). Recently, differentiation strategies have been developed
to successfully specify fate selection of differentiating hPSCs
into SC-islets (Pagliuca et al., 2014; Rezania et al., 2014). Further
refinements to these protocols have improved function and gene
expression (Ghazizadeh et al., 2017; Hogrebe et al., 2020; Mill-
man et al., 2016; Nair et al., 2019; Velazco-Cruz et al., 2020b,
2019). Nonetheless, SC-islets generated in vitro remain unequal
to cadaveric islets both functionally and transcriptionally.
Single-cell RNA sequencing (scRNA-seq) and other assays of
global transcription have been used to rigorously study and un-
cover pancreatic identities (Augsornworawat and Millman,
2020), including assessment of SC-b cell populations in diabetic
models (Balboa et al., 2018; Maxwell et al., 2020), analysis of
SC-islets from in vitro differentiation (Pagliuca et al., 2014; Veres
et al., 2019), and studying islets or islet development (Baron
et al., 2016; Byrnes et al., 2018; Enge et al., 2017; Hogrebe
et al., 2020; Muraro et al., 2016; Russell et al., 2020; Scavuzzo
et al., 2018; Segerstolpe et al., 2016; Velazco-Cruz et al., 2020a;
Xin et al., 2018). When compared to b cells from cadaveric islets,
these technologies revealed that in-vitro-derived SC-b cells lack
or have low expression of many important maturation genes,
such as MAFA and G6PC2 (Hogrebe et al., 2020; Pagliuca
et al., 2014; Veres et al., 2019). However, after transplantation,
the function and amount of INS secreted by SC-b cells increases
(Balboa et al., 2018; Hogrebe et al., 2020; Nair et al., 2019; Pa-
gliuca et al., 2014; Rezania et al., 2014; Vegas et al., 2016; Ve-
lazco-Cruz et al., 2019). The cause of this increase is unknown
and may be due to differentiation of accompanying progenitors,
remodeling of the graft, and thematuration state of cells not being
set by the in vitro conditions under which they were derived. How-
ever, further assessment of these transplanted cells has been
limited to immunostaining and functional assessment of ex vivo
grafts (Balboa et al., 2018; Bruin et al., 2015; Pepper et al.,
2017; Robert et al., 2019; Velazco-Cruz et al., 2019).
Here, we utilize scRNA-seq to elucidate the cellular identity,
maturation, and changes in gene expression of transplanted
(grafted) SC-islets compared to in-vitro-generated (stage 6)
Cell Reports 32, 108067, August 25, 2020 ª 2020 The Authors. 1
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ll
OPEN ACCESS
SC-islets and primary cadaveric islets. We demonstrate that b
and a cells differentiated from both human embryonic stem
cell (hESC) and human induced pluripotent stem cell (hiPSC)
lines undergo functional and drastic transcriptional changes af-
ter transplantation to closely resemble b and a cells from cadav-
eric islets. Specifically, for SC-b cells, we find that transplanta-
tion increases expression of many missing or lowly expressed
b cell maturation and identity genes, including MAFA, G6PC2,
MNX1, and INS, while decreasing GCG and SST. In addition,
we chart the transcriptional changes of stem-cell-derived
enterochromaffin (SC-EC) cells that were recently described to
be generated during SC-islet differentiation (Veres et al., 2019).
This is a critical resource for understanding and advancing cur-
rent directed differentiation technologies to develop novel cell
therapies for diabetes.
RESULTS
Retrieval and Identification of SC-Islet Cell Populations
after Transplantation
We differentiated a hESC and hiPSC line with our six-stage dif-
ferentiation protocol into SC-islets (Hogrebe et al., 2020) (Figures
S1A and S1B). Differentiated SC-islets were then transplanted
into the kidney capsule of streptozotocin (STZ)-induced diabetic
mice (Figure 1A). Glucose tolerance test (GTT) was performed in
transplanted diabetic mice, showing improvements in blood
glucose regulation after 4 weeks and further reversal of diabetes
at 6 months (Figure 1B). Moreover, we detected increasing
glucose stimulated human C-peptide (CP) secretion in serum
of transplanted mice (Figure 1C). After 6 months, we harvested
the kidneys from mice to extract transplanted SC-islets. These
grafts display endocrine cell protein markers including chromog-
ranin A (CHGA), Homeobox protein Nkx-6.1 (NKX6.1), CP, and
glucagon (GCG) (Figure 1D). The extracted SC-islet grafts were
processed for ex vivo analysis by single-cell dispersing the
excised kidney with collagenase D and enriching grafted cells
with a magnetic bead mouse cell depletion kit. After library prep-
aration with the 10x Genomics Chromium platform, we
sequenced 45,674 cells from isogenic matched stage 6
(in vitro) and grafted (in vivo) cells with the NovaSeq 6000 (Fig-
ures 1E and 1F). Filtering was performed to remove cells with
high mitochondrial content or high gene number, indicative of
apoptotic cells and doublets, respectively. To remove residual
mouse kidney cells, we performed unsupervised clustering of
the grafted samples to generate t-distributed Stochastic
Neighbor Embedding (tSNE) plots (Figure S1C). We identified a
cluster of cells in each sample containing low human-mapped
gene counts, which marked predominantly mouse cells (Fig-
ure S1D). TTC36, a kidney gene marker that aligns to both the
mouse and human genome, is represented in each cluster with
low gene counts in all graft samples. To verify, we generated
violin plots to show upregulated expression of TTC36 in the iden-
tified low gene count population (Figure S1E; Table S1) (Zhou
et al., 2016). For all grafted samples, we removed all cells en-
riched with TTC36 as a method to distinguish mouse cells and
remove them from subsequent analysis.
After filtering, we had 15,914 cells for analysis from stage 6
hiPSC-islets, stage 6 hESC-islets, hESC-islet grafts from three
mice, and hiPSC-islet grafts from two mice. Single-cell datasets
of the same condition, three hESC-islet grafts and two hiPSC-
islet grafts, were pooled to obtain sufficient cell numbers for sub-
sequent analyses, comparable to previously published literature
(Enge et al., 2017; Segerstolpe et al., 2016;Wang et al., 2016; Xin
et al., 2016). Single-cell analysis revealed the majority of cell
types to be pancreatic in nature for both stage 6 and grafted
cells. Within the individual sample tSNE projections, we identi-
fied key pancreatic endocrine cell populations, including SC-b,
stem-cell-derived a (SC-a), and stem-cell-derived d (SC-d) cells.
The SC-b cells identified in the sequencing data appear to match
prior reports that defined SC-b cells by the expression of CP and
NKX6.1, while the polyhormonal cells identified in prior reports
appear to be within the SC-a and SC-d cell populations in the
sequencing data (Pagliuca et al., 2014; Velazco-Cruz et al.,
2019). Other cell types, including exocrine, also persist to
some extent, as found in previous transplantation studies (Ve-
lazco-Cruz et al., 2019) (Figures 1E–1H and S1F). The fate of
these exocrine cells is hard to determine with our dataset and
has been similarly hard in other datasets (Korbutt et al., 1996).
Our cluster-matched cell types were assigned based on cell-
type-specific genes found in published scRNA-seq literature
for cadaveric and SC-islets (Table S2) (Muraro et al., 2016; Veres
et al., 2019). The fractional yields and defining genes of each cell
type can be found in Table S2. SC-b and SC-a cells are present
in both stage 6 and grafted populations. We also identify popu-
lations of proliferating SC-a cells (GCG, ARX, CRYBA2, MKI67,
PCNA, and MCM2) in stage 6 SC-islets (Figure S2A), similar to
as previously reported (Balboa et al., 2018). These proliferative
genes are not expressed in other endocrine cell types. Similarly,
identifiable SC-d cell populations are only present in stage 6 SC-
islets (Figures 1E–1H). While SST+/HHEX+ cells are found in the
grafted samples, their overall gene expression signatures are not
sufficiently different from SC-a cells to cluster separately.
Recently, SC-EC cells were found to be an off-target cell type
generated from SC-islet differentiation protocols and have
been implicated as an inhibitory cell type for SC-islet in vitro
function (Veres et al., 2019). These cells synthesize and secrete
serotonin (TPH1, SLC18A1) and are typically found in the gastro-
intestinal tract or gastric glands (Gr€un et al., 2015). We identify
SC-EC cells in stage 6 and grafted SC-islets (Figures 1E–1H).
Our analysis shows that many cell types generated in vitro by
our six-stage differentiation protocol persist in grafted SC-islets.
SC-b Cells Mature within Transplanted Grafts
To study gene expression changes that occur in SC-b cells after
transplantation, we projected individually sequenced stage 6
and grafted cells onto a combined tSNE, separated by cell line,
and quantified the percentage of each cell type in the combined
plots (Figure 2A). It is important to note that combined plots are
used for subsequent gene and gene set analysis, as the dimen-
sional reduction provided by tSNE plots depends on the samples
used, and absolute distances should not be compared across
different plots. Similarly, we designated cell types based on liter-
ature of pancreatic cell types matched to upregulated genes
within each cluster (Figure S2A; Table S3) (Muraro et al., 2016;
Veres et al., 2019). We detected 1,671 and 1,683 b cells derived
from hESC and hiPSC lines, respectively. Focusing on the SC-b




cell population (Figure 2B), we identify 5,867 genes with differen-
tial expression (adjusted p value <0.05) in grafted compared to
stage 6 SC-b cells (Table S4). Despite some variations among
SC-b cells from hiPSC and hESC sources (Figures S2B and
S2C; Table S3), which we expected due to differences in genetic
background (Kim et al., 2009; Wang et al., 2016), we observe
substantial reductions in transcriptome variations among SC-b
cells after transplantation when compared between the two lines
(Figures S2D and S2E; Table S3). Drastic and congruent tran-
scriptome changes are observed in transplanted SC-b cells
when segmented by the original derivation line (Figures 2C, 2D,
S2F, and S2G; Table S4).
Of particular interest, studied maturation genes such as INS,
MAFA, SIX2,MNX1, andG6PC2 are nowmore highly expressed
in a greater fraction of cells within the grafted SC-b cells,
whereas they were previously missing or had lower expression
Figure 1. Single-Cell Transcriptional Characterization of Stage 6 and Grafted hPSC-Islets Identifies Endocrine and Non-Endocrine Cell
Populations
(A) Schematic summary of single-cell analysis of stage 6 SC-islets and grafted SC-islets following 6 months of in vivo maturation in diabetic mice.
(B) Glucose tolerance test (GTT) at 4 weeks and 6 months after transplantation of SC-islets (n = 5).
(C) In vivo glucose-stimulated CP secretion at 0 min, before, and 60 min after glucose injection at 3 and 26 weeks post-transplantation (n = 5). *p < 0.05, ***p <
0.001 by two-way unpaired t test.
(D) Immunostaining of kidney graft explanted form SC-islet transplanted mice at 6 months. Scale bar, 100 mm.
(E–H) Individual tSNE projection (E and G) and cell population fractions (F and H) from unsupervised cluster of stage 6 and grafted hESC- and hiPSC-islets.
CHGA, chromogranin A; CP, C-peptide; EC, enterochromaffin; GCG, glucagon. Error bars represent SEM. See also Figure S1 and Table S2.
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in SC-b cells in vitro (Figures 2C and 2D; Table S4). Moreover,
many additional genes associated with mature b cells are found
more highly expressed in grafted compared to stage 6 SC-b
cells. UCN3, recognized as a b cell maturation marker from
mouse studies (Blum et al., 2012), is increased. KLF9 and
HOPX, which were identified to be upregulated in adult b cells
when compared to fetal primary b cells, are increased (Hrvatin
et al., 2014). FAM159B, ITM2B, and IGFBP7, which are regula-
tors of physiological function expressed in cadaveric b cells (Ca-
munas-Soler et al., 2020; Segerstolpe et al., 2016; Tyler et al.,
2019), are found upregulated in our grafted SC-b cells. Gene
set enrichment analysis (GSEA) reveals higher expression of
KEGG and REACTOME pathways pertaining to b cell identity
and processes in the grafted SC-b cells (Figure 2E and S2H; Ta-
ble S4).
To verify our identified SC-b cell maturation genes, we per-
formed histology stains of in-vitro-derived and transplanted
SC-islets. We stained the graft of transplanted cells for matura-
tion markers including MAFA, FAM159B, NAA20, and islet amy-
loid polypeptide (IAPP) (Figure 2F). Transplanted SC-b cells
showmarked expression of protein products from these upregu-
lated genes. Because IAPP encodes a hormone that is also
secreted by b cells, we confirmed that the transcript was lower
using real-time PCR and detected lower secretion of the protein
in stage 6 SC-b cells compared to primary islets (Figure 2G). To
test if secreted IAPP protein could be a useful biomarker corre-
lating with maturation, we measured IAPP in the serum of trans-
planted mice 3 and 26 weeks after transplantation (Figure 2H).
We found that IAPP secretion increased 10.1 ± 2.63, correlating
with the scRNA-seq results of increased IAPP transcript (Fig-
ure 2C). This is also a greater dynamic range than what we
observed with CP, which only increased 2.7 ± 0.53 during the
same time period (Figure 1C). The protein analysis here is consis-
tent with the scRNA-seq data.
Other misexpressed genes have lower expression in SC-b
cells after transplantation (Figures 2C and 2D; Table S4). We
and others previously identified several genes (CHGA, MAFB,
GCK, and GLUT1) that were overexpressed in stage 6 SC-islets
compared to cadaveric islets (Augsornworawat et al., 2019;
Hogrebe et al., 2020; Nair et al., 2019; Velazco-Cruz et al.,
2019; Veres et al., 2019) and here find that they have reduced
expression in grafted compared to stage 6 SC-b cells. We
observe reductions in GCG and SST gene expression and other
genes expressed by a and d cells (ALDH1A1, FTL, and CRYBA2)
with transplantation. Genes enriched in non-functional stem-
cell-derived INS-expressing endocrine compared to adult
cadaveric b cells (FOXA1, NR2F1, FEV, SOX11, ONECUT2,
and TCF3) (Hrvatin et al., 2014) are lowly expressed in grafted
SC-b cells.
Next, we reconstructed the single-cell data from stage 6 and
grafted SC-b cells into developmental trajectories to obtain a
greater understanding of the dynamic changes in b cell matura-
tion transcripts. Stage 6 SC-b cells from hESC and hiPSC lines
form separate branches at the initial pseudo-time state and
merge to a single trajectory that consists mainly of grafted SC-
b cells (Figures 3A and 3B), suggesting that the transcriptomes
among different cell lines becomemore similar upon maturation.
Reduction of GCG and SST is also observed with pseudo-time,
thus verifying our observation of b cell fate commitment after
transplantation (Figure 3C). Using the top 100 most differentially
expressed genes, we were able to observe a multitude of genes
that trend similarly to GCG and SST including ADLH1A1,
MAP1B, and CRYBA2 (Figure 3D; Table S6). Conversely, key b
cell maturation genes, specifically MAFA and G6PC2, increase
in expression with pseudo-time (Figures 3E and 3F). Of note,
we identified additional regulatory and identity genes including
FXYD2, IAPP, MT1X, and SAT1 to increase in concert with
MAFA and G6PC2. When evaluating the most differentially ex-
pressed genes, JUN, NEAT1, PPP1R1A, SLC30A1, and ASB9
are upregulated at the terminal end of the trajectory (Figure 3D),
indicating further b cell development.
We also analyze additional gene sets pertaining to b cell func-
tion and maturation. We see upregulation of KCNK3, SLC30A8,
and IAPP, known to support b cell function (Figures 3E, 3F, and
S3) (Camunas-Soler et al., 2020; Velazco-Cruz et al., 2019).
CACNA1C, a calcium channel subunit important for INS secre-
tion, lessens with maturation; VIPR1 and GPR119, potent GSIS
activators (Ohishi and Yoshida, 2012; Tsutsumi et al., 2002),
have intermediate activation; and ABCC9 and G6PC2, ex-
pressed in functional b cells, are present at the final state in
Figure 2. Comparison of Stage 6 and Grafted hiPSC-b and hESC-b Cell Transcriptomes
(A) Unsupervised clustering tSNE projections of hESC-islets and hiPSC-islets with islet cell-type identification and cell proportions for each individual sample
(gray).
(B) Heatmap of INS gene expression to distinguish SC-b cell population for both hESC-islet and hiPSC-islet samples.
(C) Normalized expression values for key b cell identity, maturation, functional, developmental, and newly identified gene sets compared between stage 6 and
grafted SC-b cells for both hiPSC-b and hESC-b datasets. Percentage of cells positive for designated gene is represented by circle size, and saturation indicates
low (gray) or high (blue/red) expression of the gene.
(D) Volcano plot displaying fold change (FC) differences of b cell genes between stage 6 and grafted SC-b cells of all hESC- and hiPSC-derived samples
combined. Dashed lines are drawn to define restriction of log FC value of 0.25 and log of adjusted p value 0.001. Key b cell genes are labeled and colored red.
(E) KEGG and Reactome GSEA, quantified by the normalized enrichment score (NES), for pathways upregulated in grafted hESC-b (red) and hiPSC-b (blue)
compared to stage 6 hESC-b or hiPSC-b cells, respectively. NES values and gene lists are available in Table S4.
(F) Immunostaining of stage 6 and 6-month kidney grafts containing SC-islets for identified b cell maturation markers (red) co-stained with CP (green). Scale bar,
100 mm.
(G) Analysis of IAPP gene expression with real-time PCR (left; n = 4) and secreted IAPP protein (right; n = 11, n = 8, n = 9 for stage 6 hESC-islet, stage 6 hiPSC-islet,
and HIs, respectively) in vitro. *p < 0.05, ***p < 0.001 by two-way unpaired t test.
(H) IAPP protein in serum of mice transplanted with SC-islets for 3 and 26 weeks (n = 5). ****p < 0.0001 by two-way unpaired t test.
INS, insulin; MODY, maturity onset diabetes of the young; CHGB, chromogranin B; IAPP, islet amyloid polypeptide; HI, human islet. Error bars represent SEM.
See also Figures S1 and S2 and Table S3.




grafted SC-b cells (Figure 3F). Consistent with previous HI and
SC-b cell comparison studies, we also observe reduced expres-
sion of GCK in the grafted SC-b cells. Looking into identified b
cell maturation gene sets (Veres et al., 2019), we observe all tran-
scripts, with the exception of MAFB, to increase with pseudo-
time (Figures 3F and S3). Though categorized as maturation
genes, the expression pattern ofMAFB trends similar to primary
human b cells (Hrvatin et al., 2014; Veres et al., 2019). Altogether,
our clustering and pseudo-time ordering analyses suggest that
transplanted SC-b cells display dynamic gene patterns leading
to b cell maturity.
Grafted SC-b Cells Closely Resemble Primary Human b
Cells
Previous studies show that SC-b cells are markedly different
from native adult b cells, possessing key b cell identity genes
but short of many other genes by global perspective (Pagliuca
et al., 2014). To explore if our grafted SC-b cells acquired gene
expression that better resemble native adult b cells, we per-
formed subsequent comparisons by incorporating scRNA-seq
data from three healthy cadaveric donor HIs (Xin et al., 2018)
into a new combined tSNE projection. We pooled 3,368 SC-b
cells (1,765 from hESC and 1,603 hiPSC) with cadaveric HI b
cells, making a total of 4,696 b cells for our analysis. With a total
of 10 single-cell sequencing samples, we detected all cell popu-
lations identified previously in Figure 1, which includes pancre-
atic endocrine and exocrine cell types (Figures 4A, 4B, and
S4A; Table S5) (Muraro et al., 2016; Veres et al., 2019). With
the addition of primary islet data, we now identify endothelial
cells marked by high expression of PECAM1, CD34, and
ENTPD1. Notably, we do not detect SC-EC or proliferating a
cells within cadaveric HIs (Figures 4A and 4B).
We performed differential gene expression analysis of b cells
from SC-islet grafts and native HIs. b cell identity genes (INS,
NEUROD1, and NKX2-2), maturation genes (MAFA and
G6PC2), and other notable genes (ITM2B, PDX1, GCK, and
Figure 3. Pseudo-Time Analysis Projects Stage 6 SC-b Cell Maturation into Grafted SC-b Cells after Transplantation
(A) Pseudo-time trajectory of stage 6 and grafted SC-b cells with one branching point.
(B) Distribution of SC-b cells from grafted hESC-b (purple), grafted hiPSC-b (pink), stage 6 hiPSC-b (orange), and stage 6 hESC-b cells (blue).
(C) Changes in gene expression of endocrine hormones—INS, somatostatin (SST), and GCG—along pseudo-time projection for SC-b cells. Scale: relative
expression.
(D) Analysis of top 100 branch-dependent genes determined based on clusters identified through pseudo-time analysis of SC-b cells, found in Table S4. Scale:
relative expression.
(E) Relative expression level of selected b cell genes along SC-b cell pseudo-time.
(F) Gene expression heatmap of select b cell genes focused on function and maturation along pseudo-time. Scale: normalized expression.
See also Figure S3 and Table S4.




STX1A) are strikingly similar across the two conditions (Figures
4C, S4B, and S4C; Table S6). Furthermore, b cells from native is-
lets have similar transcriptome profiles when compared to
grafted SC-b cells (Figure 4D). Quantitatively, Pearson correla-
tion shows that native b cells are more similar to grafted SC-b
cells when compared across all samples (Figure 4E; Table S6).
These results suggest that SC-b cells have the ability to acquire
native adult b cell genes when placed in an in vivo setting.
We also observe genes that are misexpressed in our grafted
SC-b cells when compared to native adult b cells. Some key
functional and b cell identity genes we identified as reduced in
our grafted SC-b cells, including NKX6-1, CHGA, IAPP, HOPX,
and EROL1B, continue to have higher expression when
compared to native islet b cells (Figures 4C, S4B, and S4C; Table
S6). Conversely, b cells from native islets have higher expression
ofmultiple endocrine hormone genes, specificallyPPY,SST, and
GCG (Figures 4C, S4B, and S4C; Table S6). We also observe Hu-
man Leukocyte Antigen (HLA) genes (B2M, HLA-B, and HLA-A)
and ribosomal protein small (RPS) and other large (RPL) genes to
be upregulated in native adult b cells (Table S6). Of note, no ma-
jor b cell identity genes were under-expressed in our grafted SC-
b cells when compared to native adult b cells.
In addition to these marked differences, we refined our differ-
entially expressed list of genes upregulated in both grafted SC-b
Figure 4. Grafted SC-b Cells Resemble Primary Human b Cells Compared to Stage 6 SC-b Cells
(A) Unsupervised tSNE projection from 10 islet datasets including stage 6 hiPSC- and hESC-islets, three grafted hESC-islets, two grafted hiPSC-islets, and three
primary HIs.
(B) Individual location of different samples within combined tSNE projection.
(C) Volcano plot displaying FC differences of b cell genes between grafted SC-b (left) and HI b cells (right). Dashed lines are drawn to define restriction of log FC
value of 0.25 and log of adjusted p value 0.001. Key b cell genes are labeled and colored red.
(D) Heatmap showing gene expression values for stage 6, grafted SC-b, and primary HI (donor) b cells of the 100 most differentially expressed genes between
stage 6 and grafted SC-b cells listed in Table S6. Scale: normalized expression.
(E) Pearson correlation matrix and hierarchical clustering to identify most similar populations among all b cell samples using top 430 variable genes. Pearson
correlation values detailed in Table S6. Scale: correlation coefficient.
See also Figure S4 and Tables S4, S5, and S6.




cells and native adult b cells (Tables S4 and S6) and established
a curated list of genes that are shared across the two conditions
(Table S6). In our list, metallothionein (MT1E, MT1F, MT1X, and
MT2A) and b cell function regulatory (FAM159B, G6PC2, and
IAPP) genes are highlighted. Notably, IAPP, FAM159B, and
MT1X were previously associated with adult HIs and are now
confirmed as maturation genes (Camunas-Soler et al., 2020;
Muraro et al., 2016). Additional genes including PEBP1, MT2A,
FXYD2, NAA20, RASD1, and SAT1 are also upregulated.
Pseudo-time ordering analysis also verified these identified
genes to be upregulated at similar expression values for both
grafted SC-b cells and native adult b cells (Figures S4D–S4F).
We validated some of our identified maturation genes using
qPCR (Figure S4G). Furthermore, we observed that a very small
fraction (2.09% and 1.20%) of stage 6 SC-b cells expressed
MAFA but still lacked expression of other important genes,
such as G6PC2 (Figures S4H and S4I). Collectively, the results
support that our grafted SC-b cells have transcriptional profiles
that more closely resemble native b cells in cadaveric HIs
compared to stage 6 cells.
SC-a Cells Mature within Transplanted Grafts
SC-a cells are generated from our six-stage SC-islet differentia-
tion protocol and account for an average of 51.8% and 11.1%
cell proportions in stage 6 and grafted SC-islets, respectively
(Table S2). While we see some variation in stage 6 SC-a cells
from different genetic backgrounds (Kim et al., 2009; Wang
et al., 2016), there is considerable convergence of grafted tran-
scriptome profiles after transplantation (Figure S5A; Table S3).
Further analysis of the SC-a cell population (Figure 5A) indicates
grafted SC-a cells undergo significant transcriptome changes
with greater expression of specific maturation genes compared
to stage 6 SC-a cells (Figures 5B–5E; Table S6). However, the
grafted SC-a cells are not as similar to HI a cells as SC-b cells
are to HI b cells (Figures 4E and 5D; Table S6). A marked differ-
ence is the reduced level of GCG and increased expression of
INS in the grafted SC-a cells compared to native islet a cells (Fig-
ures 5C, 5E, and S5B). In fact, this degree of polyhormonality and
this higher expression of FEV, an immature a cell marker (Veres
et al., 2019), are key characteristics reported in precursor a cells,
found in juvenile HIs (Ramond et al., 2018; Veres et al., 2019). Of
note, ARX, a key a cell marker, remains elevated in both stage 6
and grafted SC-a cells compared to HI a cells (Figures 5E and
S5B). The expression of proliferating genes (MKI67, PCNA,
and MCM2) are also found predominantly in the stage 6 SC-a
cell population (Figure S2A), but we did not extensively study
this population here. This population is not detected in grafted
SC-islets (Figures 1E–1H and S4A) or adult HIs and is not detect-
able in other HI a cell studies (Baron et al., 2016; Muraro et al.,
2016). Despite these differences, differential gene expression
analysis indicates stage 6 SC-a cells are maturing to a transcrip-
tional state similar to primary islet a cells. For further examination
of the SC-a cell maturation state, we curated a maturation gene
list (Table S6) from upregulated genes in grafted (Table S4) and
HI a cells (Table S6) compared to stage 6 SC-a cells.
To dynamically visualize transcriptional changes, we recon-
structed our stage 6 and grafted SC-a cell data into a pseudo-
time trajectory (Figures 5G and 5H). Similar to SC-b cells, the
hiPSC-a and the hESC-a cells formed separate branches at
the initial pseudo-time. hESC-a cells, however, are more repre-
sentative across the bulk of the trajectory. These branches
merged to form a population that consists mainly of grafted
hiPSC-a and hESC-a cells at the terminal pseudo-time, as was
observed in our b cell analysis. Of particular note, well-known
(CHGB, GCG, and LOXL4) and newly identified (SCG5 and
PARVB) genes from our a cell maturation gene list increase
with pseudo-time (Figures 5I and S5C). On the other hand,
expression of CHGA and FTL reduces with pseudo-time,
following trends observed when incorporating primary islet a
cells into the analysis (Figures S5C–S5G; Table S4). Altogether,
our results support that transplantation of SC-b and SC-a cells
induce drastic transcriptome changes to more closely resemble
their respective islet endocrine cell type.
Transcriptional Changes of EC Cells within
Transplanted Grafts
We identify SC-EC cells, an off-target of SC-islet and SC-b cell
differentiation protocols, in all stem-cell-derived samples. How-
ever, we did not detect EC cells in cadaveric HI samples (Figures
6A and S6A), consistent with prior reports (Veres et al., 2019).We
performed a comparison of the SC-EC cells before and after
transplantation. Several transcriptional changes occur after
transplantation (Figure 6B), and interestingly, transcriptome sim-
ilarity between the grafted SC-EC cells has the highest Pearson
correlation compared to other interrogated cell types (Figure 6C;
Table S4). Following transplantation, EC cell genes, including
MME, DDC, ITPR3, TAC1,CHGA, SLC18A1, andCHGB, are up-
regulated, and TPH1 protein is expressed (Figures 6D and 6E;
Table S4) (Gr€un et al., 2015; Veres et al., 2019). We also identify
new EC cell genes that increase after transplantation, such as
DUSP1 and ZFP36. Conversely, islet endocrine genes (INS,
GCG and SST) are reduced, suggesting further commitment to
the EC cell fate.
Pseudo-time ordering analysis reveals similar reconstruction
patterns observed with SC-a cells and SC-b cells (Figures 6F
and 6G). The grafted SC-EC cell populations continue to overlap
at the terminal point in pseudo-time, suggesting a uniform
commitment to EC cell fate. Genes previously found upregulated
in SC-EC cells following transplantation from differential gene
expression analysis are also increased with pseudo-time (Fig-
ures 6H, S6B, and S6C; Table S4). ZFP36 and MME are initially
lowly expressed in a few cells. However, along the pseudo-
time, they are upregulated in a greater number of cells. Elevated
genes in the grafted SC-EC cells (Table S4) may serve as matu-
ration markers. Yet, we are unable to validate this list, as HIs do
not have EC cell populations, and there are limited EC cell pri-
mary data available. Overall, we establish SC-EC cells are pre-
sent in our differentiated SC-islets, and following transplantation,
they continue to exist and change gene expression in vivo.
DISCUSSION
The ability to robustly generate pancreatic islets from hPSCs
marks an important accomplishment in developmental science
and bioregenerative medicine. Nonetheless, SC-b cells gener-
ated from current protocols have transcriptome and functional




attributes that resemble juvenile, immature b cells rather than
adult mature b cells (Hogrebe et al., 2020; Pagliuca et al.,
2014; Velazco-Cruz et al., 2019). Herein, we demonstrate that
SC-b cells, derived from both ES and iPS cell lines, can develop
into mature b cells after transplantation. Previous publications
display enhanced INS secretion with prolonged transplantation
Figure 5. Single-Cell Transcriptome and Pseudo-Time Analysis Indicates Stage 6 SC-aCells Mature during Transplantation to More Closely
Resemble HI a Cells
(A) Heatmap of GCG gene expression to distinguish SC-a cell populations within tSNE plot from Figure 4A.
(B) Normalized gene expression values for two stage 6 SC-a, five grafted SC-a, and three primary HI (donor) a cells of the 100most differentially expressed genes
between stage 6 and grafted SC-a cells listed in Table S6. Scale: normalized expression.
(C) Volcano plot displaying FC differences of a cell genes between grafted SC-a (left) and HI a cells (right). Dashed lines are drawn to define restriction of log FC
value of 0.25 and log of adjusted p value 0.001. Key a cell genes are labeled and colored red.
(D) Pearson correlation matrix and hierarchical clustering to identify most similar populations among all a cell samples using top 430 variable genes. Pearson
correlation values detailed in Table S6. Scale: correlation coefficient.
(E) Normalized expression values for key a cell identity, function, and newly identified genes among stage 6 SC-a, grafted SC-a, and primary human a cells.
Percentage of cells positive for designated gene is represented by circle size, and saturation indicates low (gray) or high (blue) expression of the gene.
(F) Immunostaining of stage 6 and 6-month kidney graft containing SC-islets for a cell markers. Scale bar, 50 mm.
(G and H) Pseudotime trajectory (G) and distribution (H) of SC-a cells from seven hPSC-a samples.
(I) Relative expression level of selected a cell genes along SC-a cell pseudo-time. Scale: relative expression. Each dot represents a different cell.
See also Figure S5 and Tables S3, S4, and S6.




times, which we replicate in our study. Herein, we use scRNA-
seq to characterize and explore the transcriptome changes
within these functionally improved cells, which has not previ-
ously been explored. We performed scRNA-seq on in-vitro-
generated stage 6 and grafted SC-islets following 6 months
transplantation in diabetic mice. In our SC-islets, we identify
key pancreatic and islet cell types, including SC-b, SC-a, SC-
d, and exocrine cells. After transplantation, the grafted SC-b
cell population acquired expression of adult HI b cell genes, ex-
pressing known maturation markers, including MAFA and
G6PC2.
The expression of genes important to b cell phenotype
changed with transplantation of SC-b cells. MAFA is widely
considered a marker of b cell maturation, but function in SC-b
cells in vitro has been achieved with little to no MAFA (Hogrebe
et al., 2020; Liu andHebrok, 2017; Nair et al., 2019; Velazco-Cruz
Figure 6. Analysis of Pseudo-Time and Single-Cell Transcriptomes of Stage 6 hPSC-ECs and Grafted hPSC-EC Cells Following Trans-
plantation
(A) Heatmap of TPH1 gene expression to distinguish SC-EC cell population within tSNE plot from Figure 4A.
(B) Gene expression values for two stage 6 SC-EC cells and five grafted SC-EC cells for the 100 most differentially expressed genes between stage 6 and grafted
SC-EC cells listed in Table S6. Scale: normalized expression.
(C) Pearson correlation matrix and hierarchical clustering to identify most similar populations among all EC cell samples using top 430 variable genes. Scale:
correlation coefficient.
(D) Expression values for key EC cell identity, function, development, and newly identified genes between stage 6 and grafted SC-EC cells.
(E) Immunostaining of stage 6 and 6-month kidney graft containing SC-islets for EC cell marker TPH1. Scale bar, 50 mm.
(F and G) Distribution (F) of SC-EC cells along pseudo-time trajectory (G) from seven SC-EC samples.
(H) Relative expression of select EC cell genes along SC-EC cell pseudo-time. Scale: relative expression. Each dot represents a different cell.
TPH1, tryptophan hydroxylase 1. See also Figure S6 and Table S4.




et al., 2019). Thus, the precise role ofMAFA in b cell maturation is
unclear. As we show SC-b cells can further mature to express
MAFA in vivo, our platform could be used in the future to interro-
gate transcriptional changes in this and other genes. We also
observe reduction of endocrine genes overexpressed in SC-b
cells in vitro (CHGA, MAFB, GCK, and GLUT1) to be more
consistent with primary HIs and reduction of GCG and SST
gene expression. An interesting observation was that GCG and
SST gene expression was actually lower in grafted SC-b cells
compared to primary HIs, likely due in part to isolation of these
primary cells (Teo et al., 2018). While prior reports have demon-
strated GCG and SST transcript in b cells from primary HIs (Se-
gerstolpe et al., 2016; Teo et al., 2018; Tyler et al., 2019), their
molecular role in primary b cells and SC-b cells is unclear.
Furthermore, in our study, we have also provided a new list of
genes corresponding with SC-b cell maturation in vivo. We vali-
dated protein expression of some new and pre-defined b cell
maturation genes. A limitation of this study and opportunities
for further investigation are further validation of other b cell and
newly identified a and EC cell markers. Another limitation of
this study is that we did not trace individual cells across different
comparisons through the report.
While the focus of this study is on b cells, a and EC cells are
also explored, as they constitute major endocrine cell popula-
tions with current differentiation methodologies. Stage 6 SC-a
cells mature after transplantation, indicated by increased a cell
maturation marker expression. However, the SC-a cells do not
resemble human primary a cells as closely as SC-b cells do to
their primary counterparts. This may be a result of our six-stage
differentiation protocol targeting the generation of SC-b, rather
than SC-a, cells. Nonetheless, we have generated a list of a
cell maturation markers that provides insight on enhancing a
cell function and targeting further maturation in SC-islet differen-
tiations. EC cells are an intestinal, serotonin-secreting endocrine
off-target cell type generated during endocrine differentiation
(Veres et al., 2019). They are present in both the stage 6 and
grafted SC-islet populations, but their effects on SC-islet func-
tion and maturation is unknown.
GSEA and pseudo-time ordering analysis revealed multiple
transcriptional genes and gene sets enriched in grafted SC-islet
subpopulations. A shared observation in grafted SC-b, SC-a,
and SC-EC cells is the increased expression of metallothionein
and FOS/JUN genes. Enrichment of these pathways indicates
further development and terminal differentiation of these cell
types. Interestingly, several identified SC-b cell maturation
genes are highly expressed prior to MAFA expression in
pseudo-time, possibly indicating they regulate MAFA expres-
sion. Potentially, prolonged exposure to factors associated
with these signaling components may lead to SC-islet, namely,
SC-b and SC-a cell, maturity in vitro. Targeting these pathways
could result in improved in vitro differentiation protocols.
The approach in this study involved the transplantation SC-b
cells into mice with pre-existing STZ-induced diabetes. Howev-
er, the conditions of optimal maturation, such as transplantation
time, diabetic model, and STZ induction before or after trans-
plant, are unknown and would be an interesting study. Cells in
an in vivo setting, particularly when not in their natural organ,
may undergo de-differentiation or trans-differentiation to
become other cell types (Teo et al., 2018; Ye et al., 2015).
Because we did not observe progenitor populations in our
sequencing data, we believe that themajority of our transplanted
populations are retained to their identity. However, it may be
possible that some SC-a cell or exocrine cell populations may
trans-differentiate into INS-producing cells as demand for blood
INS and GCG changes overtime (Ye et al., 2015), and this study
did not utilize lineage tracing. An additional limitation of this study
was the yields of SC-b cells we recovered from individual mice,
ranging from 111 to 560 SC-b cells. This prompted us to pool the
results from five mice for most of the analysis in this study, but
improvements, such as better purification, additional mice, and
more differentiations, would better enable robust studies.
Furthermore, incorporating the primary HI datasets caused small
variations in identified cell types, although overall gene expres-
sion differences were not meaningfully affected. An additional
limitation is the technical processing of scRNA-seq, which
conceivably may yield free-floating mRNA transcripts yielding
false positives (Sachs et al., 2020). However, our analysis here
of the cell-defining and hormone transcripts comparisons
among cell types was significantly different between endocrine
and non-endocrine cell types, as we have shown previously
(Maxwell et al., 2020), making this possibility unlikely.
In conclusion, we provide a resource thoroughly detailing the
maturation of SC-b cells through in vivo transplantation. SC-b
cells derived from both hiPSC and hESC lines are capable of
developing into cells transcriptionally similar to primary human
b cells. This dataset provides valuable information on potential
genes and target pathways thatmay contribute to understanding
human b cell maturation following transplantation. More impor-
tantly, it can lead to further developments in SC-b cell generation
for cell replacement therapies.
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Balboa, D., Saarimäki-Vire, J., Borshagovski, D., Survila, M., Lindholm, P.,
Galli, E., Eurola, S., Ustinov, J., Grym, H., Huopio, H., et al. (2018). Insulin mu-
tations impair beta-cell development in a patient-derived iPSC model of
neonatal diabetes. eLife 7, e38519.
Baron, M., Veres, A., Wolock, S.L., Faust, A.L., Gaujoux, R., Vetere, A., Ryu,
J.H., Wagner, B.K., Shen-Orr, S.S., Klein, A.M., et al. (2016). A Single-Cell
Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter- and
Intra-cell Population Structure. Cell Syst. 3, 346–360.e344.
Blum, B., Hrvatin, S., Schuetz, C., Bonal, C., Rezania, A., and Melton, D.A.
(2012). Functional beta-cell maturation is marked by an increased glucose
threshold and by expression of urocortin 3. Nat. Biotechnol. 30, 261–264.
Bruin, J.E., Asadi, A., Fox, J.K., Erener, S., Rezania, A., and Kieffer, T.J. (2015).
Accelerated Maturation of Human Stem Cell-Derived Pancreatic Progenitor
Cells into Insulin-Secreting Cells in Immunodeficient Rats Relative to Mice.
Stem Cell Reports 5, 1081–1096.
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., and Satija, R. (2018). Inte-
grating single-cell transcriptomic data across different conditions, technolo-
gies, and species. Nat. Biotechnol. 36, 411–420.
Byrnes, L.E., Wong, D.M., Subramaniam, M., Meyer, N.P., Gilchrist, C.L.,
Knox, S.M., Tward, A.D., Ye, C.J., and Sneddon, J.B. (2018). Lineage dy-
namics of murine pancreatic development at single-cell resolution. Nat. Com-
mun. 9, 3922.
Camunas-Soler, J., Dai, X.Q., Hang, Y., Bautista, A., Lyon, J., Suzuki, K., Kim,
S.K., Quake, S.R., and MacDonald, P.E. (2020). Patch-Seq Links Single-Cell
Transcriptomes to Human Islet Dysfunction in Diabetes. Cell Metab. 31,
1017–1031.e4.
Enge, M., Arda, H.E., Mignardi, M., Beausang, J., Bottino, R., Kim, S.K., and
Quake, S.R. (2017). Single-Cell Analysis of Human Pancreas Reveals Tran-
scriptional Signatures of Aging and Somatic Mutation Patterns. Cell 171,
321–330.e314.
Ghazizadeh, Z., Kao, D.I., Amin, S., Cook, B., Rao, S., Zhou, T., Zhang, T.,
Xiang, Z., Kenyon, R., Kaymakcalan, O., et al. (2017). ROCKII inhibition pro-
motes the maturation of human pancreatic beta-like cells. Nat. Commun. 8,
298.
Gr€un, D., Lyubimova, A., Kester, L., Wiebrands, K., Basak, O., Sasaki, N.,
Clevers, H., and van Oudenaarden, A. (2015). Single-cell messenger RNA
sequencing reveals rare intestinal cell types. Nature 525, 251–255.
Hogrebe, N.J., Augsornworawat, P., Maxwell, K.G., Velazco-Cruz, L., andMill-
man, J.R. (2020). Targeting the cytoskeleton to direct pancreatic differentiation
of human pluripotent stem cells. Nat. Biotechnol. 38, 460–470.
Hrvatin, S., O’Donnell, C.W., Deng, F., Millman, J.R., Pagliuca, F.W., DiIorio,
P., Rezania, A., Gifford, D.K., and Melton, D.A. (2014). Differentiated human
stem cells resemble fetal, not adult, b cells. Proc. Natl. Acad. Sci. USA 111,
3038–3043.
Kim, A., Miller, K., Jo, J., Kilimnik, G., Wojcik, P., and Hara, M. (2009). Islet ar-
chitecture: A comparative study. Islets 1, 129–136.
Korbutt, G.S., Elliott, J.F., Ao, Z., Smith, D.K., Warnock, G.L., and Rajotte, R.V.
(1996). Large scale isolation, growth, and function of porcine neonatal islet
cells. J. Clin. Invest. 97, 2119–2129.
Latres, E., Finan, D.A., Greenstein, J.L., Kowalski, A., and Kieffer, T.J. (2019).
Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insu-
lin Delivery Devices and Cell Therapy. Cell Metab. 29, 545–563.
Liu, J.S., and Hebrok, M. (2017). All mixed up: defining roles for b-cell subtypes
in mature islets. Genes Dev. 31, 228–240.
Maxwell, K.G., Augsornworawat, P., Velazco-Cruz, L., Kim, M.H., Asada, R.,
Hogrebe, N.J., Morikawa, S., Urano, F., and Millman, J.R. (2020). Gene-edited
human stem cell-derived b cells from a patient with monogenic diabetes
reverse preexisting diabetes in mice. Sci. Transl. Med. 12, eaax9106.
Millman, J.R., Xie, C., Van Dervort, A., G€urtler, M., Pagliuca, F.W., and Melton,
D.A. (2016). Generation of stem cell-derived b-cells from patients with type 1
diabetes. Nat. Commun. 7, 11463.
Muraro, M.J., Dharmadhikari, G., Grun, D., Groen, N., Dielen, T., Jansen, E.,
van Gurp, L., Engelse, M.A., Carlotti, F., de Koning, E.J., et al. (2016). A Sin-
gle-Cell Transcriptome Atlas of the Human Pancreas. Cell Syst. 3, 385–
394.e383.
Nair, G.G., Liu, J.S., Russ, H.A., Tran, S., Saxton, M.S., Chen, R., Juang, C., Li,
M.L., Nguyen, V.Q., Giacometti, S., et al. (2019). Recapitulating endocrine cell
clustering in culture promotes maturation of human stem-cell-derived b cells.
Nat. Cell Biol. 21, 263–274.
Ohishi, T., and Yoshida, S. (2012). The therapeutic potential of GPR119 ago-
nists for type 2 diabetes. Expert Opin. Investig. Drugs 21, 321–328.




Pagliuca, F.W., Millman, J.R., G€urtler, M., Segel, M., Van Dervort, A., Ryu, J.H.,
Peterson, Q.P., Greiner, D., and Melton, D.A. (2014). Generation of functional
human pancreatic b cells in vitro. Cell 159, 428–439.
Pepper, A.R., Pawlick, R., Bruni, A., Wink, J., Rafiei, Y., O’Gorman, D., Yan-Do,
R., Gala-Lopez, B., Kin, T., MacDonald, P.E., and Shapiro, A.M.J. (2017).
Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes
Post Transplantation in a Prevascularized Subcutaneous Site. Stem Cell Re-
ports 8, 1689–1700.
Qiu, X., Hill, A., Packer, J., Lin, D., Ma, Y.A., and Trapnell, C. (2017). Single-cell
mRNA quantification and differential analysis with Census. Nat. Methods 14,
309–315.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rat anti C-peptide DSHB Cat#GN-ID4; RRID:AB_2255626
Mouse anti NKX6-1 DSHB Cat#F55A12; RRID:AB_532379
Rabbit anti Glucagon Cell Marque Cat#259A-18; RRID:AB_1158356
Goat anti PDX1 R&D Systems Cat#AF2419; RRID:AB_355257
Rabbit anti CHGA ABCAM Cat#ab15160; RRID:AB_301704
Rabbit anti MAFA LifeSpan Bioscience Cat#LP9872; RRID:AB_2665528
Rabbit anti FAM159B Invitrogen Cat#PA5-52855; RRID:AB_2641287
Rabbit anti NAA20 Invitrogen Cat#PA5-66574; RRID:AB_2663038
Rabbit anti IAPP Sigma Aldrich Cat#PA5-84142; RRID:AB_2791294
Sheep anti ARX Invitrogen Cat#PA5-47896; RRID:AB_2605931
Sheep anti TPH1 EMD Millipore Cat#AB1541; RRID:AB_90754
Sheep anti Trypsin R&D Cat#AF3586; RRID:AB_2846900
Mouse anti KRT19 Dako Cat#M0888; RRID:AB_2234418
anti-rat-alexa fluor 488 Invitrogen Cat#a21208; RRID:AB_141709
anti-rabbit-alexa fluor 488 Invitrogen Cat#a21206; RRID:AB_2535792
anti-rat-alexa fluor 488 Invitrogen Cat#a21208; RRID:AB_141709
anti-mouse-alexa fluor 594 Invitrogen Cat#a21203; RRID:AB_141633
anti-rabbit-alexa fluor 594 Invitrogen Cat#a21207; RRID:AB_141637
anti-goat-alexa fluor 594 Invitrogen Cat#a11058; RRID:AB_2534105
anit-sheep-alexa fluor 594 Invitrogen Cat#a11016; RRID:AB_10562537
Biological Samples
Healthy Human Islets Prodo Labs N/A
Chemicals, Peptides, and Recombinant Proteins
mTeSR1 StemCell Technologies Cat#05850
Y27632 Abcam Cat#ab120129
Matrigel Corning Cat#356230





Paraformaldehyde Electron Microscopy Science Cat#15714
Donkey Serum Jackson Immunoresearch Cat#017-000-121
Triton X-100 Acros Organics Cat#327371000
DMEM MilliporeSigma Cat#D6429
Fetal Bovine Serum MilliporeSigma Cat#F4135
Histo-clear II Electron Microscopy Sciences Cat#64111-04
Histogel Thermo Scientific Cat#Hg-4000-012
0.5 M EDTA Ambion Cat#AM9261
200 proof ethanol Decon Cat#2716
STZ R&D Cat#1621500
Critical Commercial Assays
Ultrasensitive C-Peptide Elisa Mercodia Cat#10-1141-01
Human Amylin Elisa Miltenyi Cat#EZHA-52K
(Continued on next page)





REAGENT or RESOURCE SOURCE IDENTIFIER
RNeasy Mini Kit QIAGEN Cat#74016
High Capacity cDNA Reverse Transcriptase
Kit
Applied Biosystems Cat#4368814
PowerUp SYBR Green Master Mix Applied Biosystems Cat#A25741




raw and processed single cell RNA seq data
– Stage 6 hESC-islet, 3 Grafted hESC-islet,
2 Grafted hiPSC-islet
This Paper GEO: GSE151117
raw and processed single cell RNA seq data
– Stage 6 hiPSC-islet
Maxwell et al., 2020 GEO: GSE139535
raw and processed single cell RNA seq data
– Human Islets
Xin et al., 2018 GEO: GSE114297
Experimental Models: Cell Lines
Human: HUES8 hESC HSCI hES Cell Line: HUES-8




The Jackson Laboratories JAX: 005557; RRID:IMSR_JAX:005557
Oligonucleotides
Primers for this study, see Table S1 This paper N/A
Software and Algorithms
Fiji ImageJ ImageJ public freeware https://imagej.net/Fiji/Downloads;
RRID:SCR_003070










Seurat v2.3.4 Butler et al., 2018 https://satijalab.org/seurat/install.html;
RRID:SCR_007322
Monocle v2.12.0 Qiu et al., 2017 http://cole-trapnell-lab.github.io/
monocle-release/docs/#installing-monocle
Other
Vi-Cell XR Beckman Coulter Cat#Vi-Cell XR
Tanswells Corning Cat#431752
#1.5 glass bottom 96 well plate Cellvis Cat#963-1.5H-N
8-channel peristaltic pump ISMATEC Cat#ISM931C
Inlet/outlet two-stop tubing ISMATEC Cat#070602-04i-ND
Dispensing nozzle BioRep Cat#Peri-Nozzle
Connection tubbing BioRep Cat#Peri-TUB-040
Bio-Gel P-4 Bio-Rad Cat#150-4124
Cell Chamber BioRep Cat#Peri-Chamber
Pressure cooker Electron Microscopy Sciences Model#Retriever 2100
DAPI Fluoromount-G SouthernBiotech Cat#0100-20
(Continued on next page)






Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jeffrey R.
Millman (jmillman@wustl.edu).
Materials Availability
HUES8 cell line is available through Harvard StemCell Institute (HSCI). TheWS4corr cell line is available upon request to Lead Contact
with required MTA.
Data and Code Availability
The single cell RNA sequencing data from this study is made available at the Gene Expression Omnibus (GEO). The accession num-
ber for the raw and processed Stage 6 hESC-islet and all Grafted SC-islet data is GEO: GSE151117. The accession number for the
raw and processed Stage 6 hiPSC-islet data is GEO: GSE139535. The accession number for the raw and processed human islet data
is GEO: GSE114297.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal models
Male, 7 wk old, NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice (Jackson Laboratories; stock no. 005557) were used in this study. Mice
were fed on chow diet and on a 12 hour light/dark cycle. Animals were randomly assigned to experimental groups. All animal studies
performed in this research were in accordance with Washington University International Care and Use Committee (IACUC)
regulations.
Human cell lines
Two human PSC lines were used in this study including an hESC line (HUES8) and an hiPSC (WS4corr) line. Both cell lines are authenti-
cated and have normal karyotype. The sex of HUES8 andWS4corr aremale and female, respectively. The cells were cultured inmTeSR1
(StemCell Technologies; 05850) in a 5%CO2 incubator at 37
C.Cells were single cell dispersedwith TrypLE (Life Technologies; 12-604-
039) and passaged every 3-4 days. A Vi-Cell XR (Beckman Coulter) counted viable single cells and we seeded 1.1x105 cells/cm2 cells
onto tissue culture-treated flasks, coated with DMEM-diluted (GIBCO, 11965-084) Matrigel-coated (Fisher, 356230) for propagation
in mTeSR1 with 10mM Y27532 (Abcam; ab120129). All work for this study was performed in accordance with the Embryonic Stem
Cell Research Oversight (ESCRO) committee through Washington University in St. Louis.
Primary cell culture
Cadaveric human islets were purchased from Prodo Labs and cultured in islet media (CMRL Supplemented (Mediatech; 99-603-CV)
with 10% Fetal Bovine Serum (GE Healthcare; SH3007003)). For RNA, donor islets were from a 54 year-old Hispanic female. Details
for donor islets for sequencing comparison are as follows (1) Caucasian, 32 years, female, (2) Hispanic, 23 years, male, (3) Caucasian,
49 years, male.
Stem cell-derived b cell differentiation
Thedifferentiation isbasedonourpreviouspublication (Hogrebeetal., 2020).UndifferentiatedhPSCsweresinglecelldispersed,counted,
and seeded onto tissue culture plastic treated flaskswithmTeSR1 and 10mMY27532 at 5.2x105 cells/cm2. After 24 hours, differentiation
began usingmedias and added factors. The differentiation protocol including basemedia formulation and differentiation factors is avail-
able in TableS1. 7days into stage6, cellsweredispersedwithTrypLEand seeded~5x106 cells into an individualwell of a 6-well platewith
4 mL of ESFMmedia on an OrbiShaker (Benchmark) at 100 RPM. Cells were used for transplantation between day 13-16 in stage 6.
METHOD DETAILS
Mouse Transplants
All animal studies performed in this researchwere in accordancewithWashingtonUniversity International Care andUseCommittee (IA-
CUC) regulations. Prior to transplantation of cells, male, 7 wk old, NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice (Jackson Laboratories;
Continued
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Phosphate-Buffered Saline (PBS) Corning Cat#21-040-CV
micro coverslip VWR Cat#48393-081




stock no. 005557) were treated with 45 mg/kg streptozotocin (STZ; R&D; 1621500) in 0.9% sterile saline (Moltox; 51-405022.052) for 5
consecutive days. Mice were diabetic (blood glucose > 500 mg/dL) 8 days after the final STZ injection. Surgery and assessments were
performed by unblinded individuals and mice were randomly assigned to experimental groups. For SC-islet transplantation, mice were
anesthetized with isoflurane and injected with ~5x106 SC-islet cells under the kidney capsule, from either hiPSC (n = 3) or hESC (n = 2)
derived SC-b cells. Mice were monitored for 6 months after transplantation before removal of the transplanted kidney for SC-islet
retrieval. For glucose tolerance tests (GTT) and in vivo glucose stimulated c-peptide secretion, mice were fasted for 4 hr and injected
with 2 g glucose/kg body weight. For GTT, blood glucose wasmeasured every 30min from 0 to 120 min with a Contour Blood Glucose
MonitoringSystem (Bayer; 9545C). For in vivoglucose stimulatedc-peptide secretion, serumwascollectedbeforeand1hr after glucose
stimulation.HormoneswerequantifiedbycollectingserumandmeasuringC-peptide and IAPPwith theHumanUltrasensitiveC-Peptide
ELISA kit (Mercodia; 10-1141-01) and Human Amylin ELISA kit (Miltenyi; EZHA-52K), respectively.
Immunostaining
Stage 6 clusters and excised transplant kidneys were fixed overnight in 4% paraformaldehyde (PFA) (Electron Microscopy Science;
15714) at 4C. Fixed kidneys and Stage 6 clusters, suspended in Histogel (Thermo Scientific; hg-4000-012), were further processed
by the Division of Comparative Medicine (DCM) Research Animal Diagnostic Laboratory Core at Washington University. Histoclear
(Electron Microscopy Sicences; 64111-04) removed paraffin from slides containing both Stage 6 and kidney sections. Sections were
then rehydrated and antigens were retrieved in a pressure cooker (Proteogenix; 2100 Retriever) with 0.05MEDTA (Ambion; AM9261).
Slides were blocked and stained with primary antibodies diluted in immunostaining solution (PBS (Fisher; MT21040CV) with 0.1%
Triton X (Acros Organics; 327371000) and 5% donkey serum (Jackson Immunoresearch; 017000-121)) overnight at 4C,
stained with diluted secondary antibodies for 2 hr at room temperature, and stained for DAPI (SouthernBiotech; 0100-20). The
immunostained cells and grafts were imaged with a Nikon A1Rsi confocal microscope. Antibody details and dilutions are available
in Table S7.
Tissue and Cell Preparation for Sequencing
Stage 6 SC-islet preparation. At stage 6 day 14, SC-islets were washed with PBS and single cell dispersed with TrypLE at 37C for
~20 minutes. The dispersed cells were centrifuged, counted, and resuspended in DMEM for library prep.
Grafted SC-islet cell retrieval. Transplanted mice were euthanized through cervical dislocation and the kidney transplanted
with SC-islets were removed. Excess scar tissue and fat was removed from around the kidney. Images were taken of the kid-
neys to visualize the transplanted cells. The kidney was sliced into several small pieces with a razor blade and placed into a
solution of 2mg/mL collagenase D (Sigma; 11088858001) in RPMI (GIBCO; 11875-085). The tissue was incubated at 37C
for 45 min. PBS was added to the solution and additional breakup was enforced with a pipette before filtering the cells through
a 70mm cell strainer (Corning; 431751). Collected flow through was centrifuged, supernatant was removed, and resuspended
with MACS buffer (0.05% BAS in PBS). A Miltenyi mouse cell isolation kit (kit, 130-104-694; LS column, 130-042-401) was
used to remove excess mouse cells from the cell solution. Cells in flow through were collected, centrifuged, counted, and re-
suspended in DMEM for library prep.
Single-cell RNA sequencing preparation
Single cell dispersed cells were delivered toWashington University in St. Louis Genome Technology Access Center (GTAC) for library
preparation and sequencing. For library preparations, the Chromium Single Cell 30 Library andGel Bead Kit v2 was used following the
provided protocol. In summary, a microfluidic platform is used to profile digital gene expression for individual cells by creating an
emulsion for each cell with a unique barcoded cDNA, breaking the emulsion, and amplifying the cDNA. The library was sequenced
with a NovaSeq 6000 System (Illumina) at the recommended 26x98bp. Gene expression levels found in violin plots and heatmaps are
displayed in Log(normalized read count) and normalized average gene expression, respectively.
Single-cell RNA sequencing data analysis: Raw Data Processing
Seurat v2.3.4 was used for single cell analyses and comparison between all groups (Butler et al., 2018). Monocle v2.12.0 was used for
pseudotime analysis between Stage 6 and grafted SC-b cells (Qiu et al., 2017; Trapnell et al., 2014) and WS4corr Stage 6 data is from
Maxwell et al. (https://doi.org/10.1126/scitranslmed.aax9106) SC-islet samples were aligned to the human genome and filtered out
low gene counts (< 500 for grafted and < 3000 for Stage 6) and high mitochondrial percentages (> 20%) for further data analysis,
indicating doublets, debris, and dying cells. This filtering removed several mouse cells present in the grafted SC-islet samples.
The minimum number of genes is lower for the grafted compared to Stage 6 SC-islet samples to filter out the mouse cells, because
our datasets are aligned to the human genome, therefore the mouse cells have low gene counts. Therefore, we clustered the grafted
SC-islet samples and identified the clusters with low gene counts.We identified TTC36, a kidney genewhich is present in bothmouse
and human genomes, to also be highly expressed in the low gene number clusters. We removed all cells with TTC36 log-normalized
expression > 3, to remove all remaining mouse cells from further analysis. The genes defining the cell cluster that was identified as
mouse cells can be found in Table S1. Each sample dataset was normalized with global-scaling normalization. FindVariableGenes
function removed outlier genes using a scaled z-score dispersion.





For individual tSNE plots, cells with similar gene expression patterns were plotted near each other based on PCA using the FindClus-
ters function. We used a resolution of 0.2 and 5 dimensions to generate tSNE plots for each individual sample (Stage 6 iPS SC-islets,
Stage 6 ES SC-islets, 3 Grafted ES SC-islets, 2 Grafted iPS SC-islets). The top 50 genes that separated each cluster within the in-
dividual samples were identified with FindAllMarkers and these gene sets were used to designate the different SC-islet cell types
including beta, alpha, and delta cells. These gene lists can be found in Table S2. The FeaturePlot function was used to visualize
expression of specific genes across the different clusters, represented in tSNE plots. Violin plots were generated to compare the
expression of specific genes for the SC-b cell populations within the SC-islets for each sample.
DE between Stage 6 and Grafted SC-islets
Wecombine datasets for the samehPSC source using canonical correlation analysis (CCA)withRunMultiCCA (num.ccs = 10). TheCCA
subspacesare alignedwithAlignSubspace.Unsurpervised tSNEplotsweregenerated for the combineddatasetwithRunTSNEusing 17
dimensions. Clusters were designated specific cell types based on differentially expressed genes in each cluster compared to all other
clusters, identified with FindMarkers. These gene lists can be found in Table S3. For further analyses, we compare Stage 6 and Grafted
SC-b cells byonly comparing themost enriched INS b cell cluster. Additionally, wedo this for SC-a andSC-ECcells.Weare able to iden-
tify all differentially expressed genes for SC-b, SC-a, and SC-EC cells between conditions using FindMarkers with a log fold change
threshold of 0.25; these genes can be found in Table S4. We generate a heatmap for the top differentially expressed genes.
Pathway Enrichment
Genes defining branch points in pseudotime analysis and between sample groups were analyzed for KEGG and GO pathway enrich-
ment and differential expression of HALLMARK gene sets by GSEA (4.0.2). Top enriched genes for the identified pathways and gene
sets, with NES scores above 1.0 or below 1.0 and FDR q-value < 0.25 for either or both of the derived cell line conditions, were
considered in our analysis.
Pseudotime Trajectory with Monocle
Filtered scRNA-seq data containing only b, a, or EC cells from Seurat was transferred for subsequent pseudotime trajectory analysis
using Monocle v 2.12.0 (Trapnell et al., 2014). The data was reanalyzed by clustering the datasets using clusterCells to identify Stage
6 and Grafted populations. Differentially expressed genes between the two identities were calculated using differentialGeneTest. We
used the top 800, 1000, 1500 genes by lowest q-value to reduce dimensions usingDDRTreemethod for b, a, or EC cells, respectively.
Cells were ordered using the orderCells function and pseutdotime was defined by selecting states representative of Stage 6 cells
being the initial state. The pseudotime heatmap and gene plots were generated using plot_pseudotime_heatmap and plot_gene-
s_in_pseudotime, respectively. The top differentially expressed genes between branches of pseudotime were defined for b, a,
and EC cell populations. The list of genes can be found in Table S4.
Comparison to human islets
Next, we compare our Stage 6 and Grafted SC-islets, and specifically SC-b and SC-a cells, to primary human islets from cadaveric
donors. The human islet datasets come from Xin et al., 2018 (https://doi.org/10.2337/db18-0365) and can be found at Gene Expres-
sion Omnibus database with accession number GEO: GSE114297. We selected three human islet patients for our comparison anal-
ysis. As previously described, 10 datasets (Stage 6 SC-islets (iPSC and ESC), grafted SC-islets (iPSC (n = 2) and ESC (n = 3)), human
islet donors (n = 3)) were normalized and subspaces were aligned using CCA to generate unsupervised tSNE plots with resolution of
0.1 and 30 dimensions. Clusters were designated specific cell types based on differentially expressed genes in each cluster
compared to all other clusters, identified with FindMarkers. These gene lists can be found in Table S5. The combined tSNE plot is
used to specifically compare b, a, and EC cells among samples, by selecting cells containing the INS, GCG, or TPH1 gene (low.thres-
holds = c(0.1)). In addition we analyzedMAFA+ b cells fromwithin the b cell enriched cluster (MAFA log-normalized expression > 0.2).
Differential expression of the b, MAFA+ b, and a cells from each sample (Stage 6, Grafted, Human Islet) were identified. A heatmap
and/or correlation matrix was generated reflecting each sample’s expression of the differentially expressed genes or transcriptome
similarity, respectively. A list of the genes differentially expressed for a specific cell type, between human islet and Stage 6 or human
islet and Grafted stem cell-derived cells can be found in Table S6. For correlation matrix, the average expression levels of the most
differentially expressed genes were used and generated by Pearsonmethod using cor. Values for the correlation matrix can be found
in Table S6. Pseudotime trajectory construction with monocle was also used for b and a cells in combination with human islet data to
generate branching trajectories and gene plots in pseudo-time.
Real-Time PCR
RNA from human islets and Stage 6 hiPSC-b and hESC-b cells was extracted using an RNeasy Mini Kit (QIAGEN; 74016) and DNase
treatment (QIAGEN; 79254). cDNA was synthesized using the High Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems;
4368814) and a thermocycler (Applied Biosystems; A37028). PowerUp SYBR Green Master Mix (Applied Biosystems; A25741)
generated real-time PCR reactions in a StepOne Plus (Applied Biosystems). Data was analyzed with the DDCt methodology. TBP
and GUSB were used for normalization and primer sequences are available in Table S1.





Data was analyzed using Rstudio version 3.6.1 with Seurat version 2.3.4 (Butler et al., 2018) and Monocle version 2.12.0 (Qiu et al.,
2017; Trapnell et al., 2014).
IAPP Secretion in vitro
To quantify IAPP protein secretion in vitro, the cells were cultured on transwells in a solution of 128 mM NaCl, 5 mM KCl, 2.7 mM
CaCl2, 1.2 mM MgSO4, 1 mM Na2HPO4, 1.2 mM KH2PO4, 5 mM NaHCO3, 20 mM glucose, 10 mM HEPES (GIBCO; 15630-080)
and 0.1% bovine serum albumin (Proliant; 68700) for 1 hr. The solution was collected and IAPP quantified with the Human Amylin
ELISA kit.
QUANTIFICATION AND STATISTICAL ANALYSIS
GraphPad Prism 8.2.1 was used to calculate two-sided unpaired and paired t tests. p < 0.05 was considered statistically significant.
Data is displayed asmean ± s.e.m. Sample size, n, represents total biological replicates. Tests used for individual panels, sample size
(n), and statistical parameters are detailed in figure legends.




Cell Reports, Volume 32
Supplemental Information
Single-Cell Transcriptome Profiling
Reveals b Cell Maturation in
Stem Cell-Derived Islets after Transplantation









Punn Augsornworawat1,2,†, Kristina G. Maxwell1,2,†, Leonardo Velazco-Cruz1, and Jeffrey R. 
Millman1,2,3* 
 
1Division of Endocrinology, Metabolism and Lipid Research, Washington University School of 
Medicine. 
Campus Box 8127 
660 South Euclid Avenue 
St. Louis, MO 63110 
USA 
 
2Department of Biomedical Engineering, Washington University in St. Louis. 
1 Brookings Drive 





†These authors contributed equally 
 
*To whom correspondence should be addressed: 
Jeffrey R. Millman, jmillman@wustl.edu  
2 
 




Figure S1. Kidney cell removal from grafted SC-islet datasets. Related to Figure 1. (A) 
Quantified fraction of cells and (B) representative flow cytometry dot plots expressing or co-
expressing pancreatic progenitor (PP) and β cell (C-Peptide, NKX6.1) or endocrine (CHGA) 
markers for hESC-PP  (n=4) and hiPSC-PP (n=4) or Stage 6 hESC-islets (n=4) and hiPSC-islets 
(n=4), respectively. n.s., not significant by two-way unpaired t-test. (C) Unsupervised tSNE 
projection for individual Grafted SC-islet samples, identifying different cell type clusters. (D) 
Feature tSNE plot displaying number of genes (nGene) per cell, represented by individual dots. 
(E) Violin plots representing high TTC36 expression in individual clusters for each tSNE 
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projection in (C). Scale: Log(Normalized read counts). (F) Immunostaining of sectioned Stage 6 
and Grafted SC-islets for exocrine cell markers. Scale bar, 100 µm. Error bars represent s.e.m.  




Figure S2. Identification and characterization of hiPSC-islet and hESC-islet cell types. 
Related to Figures 1 and 2. (A) Heat map displaying gene expression profiles of individual cell 
types represented in Figures 1A and 1C for cell type-specific genes (bottom x axis, gene name; 
top x axis, cell type-matched to genes). Each row is associated with a cell type (left y axis) and 
sample (right y axis). Scale: Normalized Expression (B) Volcano plot displaying fold change 
(FC) differences and (C) violin plots of β cell genes between Stage 6 hiPSC-β and hESC-β 
cells. Scale: Log(Normalized read counts). (D) Volcano plot displaying FC differences and (E) 
violin plots of β cell genes between Grafted hiPSC-β and hESC-β cells. Scale: Log(Normalized 
read counts). Volcano plot displaying FC differences between Stage 6 and Grafted (F) hESC-β 
and (G) hiPSC-β cells. Dashed lines are drawn to define restriction of log FC value of 0.25 and -
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log of adjusted p-value 0.001. Key β cell genes are labeled and colored red. (H) KEGG and 
Reactome GSEA, quantified by the normalized enrichment score (NES), for pathways 
upregulated in Stage 6 hESC-β (pink) and hiPSC-β (royal blue) compared to Grafted hESC-β or 
hiPSC-β cells, respectively. NES values and gene lists are available in Table S4. EC, 




Figure S3. Additional pseudo-time characterization of SC-β cells. Related to Figure 3. (A) 
Expression of additional known and newly identified β cell maturation genes along pseudo-time. 





Figure S4. Cell cluster identification and additional characterization of primary human 
islets, Grafted, and Stage 6 SC-islets. Related to Figure 4. (A) Heat map displaying gene 
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expression profiles of individual cell types represented in Figure 4A for cell type-specific genes 
(bottom x axis, gene name; top x axis, cell type associated with specific gene). Each row is 
associated with a cell type (left y axis) and sample (right y axis and colored legend). Scale: 
Normalized Expression. (B) Normalized expression values for key β cell identity, maturation, 
functional, and newly identified genes compared between all β cell samples. Percentage of cells 
positive for designated gene is represented by circle size and saturation indicates low (grey) or 
high (purple) expression of the gene. (C) Violin Plots of key β cell identity genes compared 
between all β cell samples. Scale: Log(Normalized read counts). (D) Pseudo-time trajectory of 
Stage 6, Grafted, and Human Islet β cells with branching points. (E) Distribution of β cells from 
Grafted hESC-β (purple), Grafted hiPSC-β (pink), Stage 6 hiPSC-β (orange), Stage 6 hESC-β 
(blue), and Human Islet (red) β cells. (F) Expression of select β cell genes along SC-β cell 
pseudo-time. Scale: Relative Expression. (G) Real-time PCR analysis of the total Stage 6 
hiPSC-islet (n=3; pink), hESC-islet (n=3; blue), and human islet (n=3; green) population 
measuring expression of identified β cell genes that change with maturation. (H) Violin plots of 
MAFA expression show individual cells in each condition for the identified β cell population from 
the tSNE projection in Figure 4A. Dotted line represents cut off for β cells to be considered 
MAFA+ for analysis in the following panel. Stage 6 hESC-β and Stage 6 hiPSC-β only had 
2.09% and 1.20% MAFA+ cells, respectively, with this threshold. Scale: Log(Normalized read 
counts). (I) Violin plot β cell genes for MAFA+ cells in panel (H). Scale: Log(Normalized read 
counts). (J) Venn diagram highlighting number of β cells identified in Figure 2 and Figure 4; and 
correlation matrix (using top 500 variable genes) highlighting similarities between β cells 





Figure S5. Additional characterization of primary human α and SC-α cells. Related to 
Figure 5. (A) Volcano plot displaying fold change (FC) differences of α cell genes between 
Stage 6 (left) and Grafted (right) hiPSC-β and hESC-β cells. Dashed lines are drawn to define 
restriction of log FC value of 0.25 and -log of adjusted p-value 0.001. Key α cell genes are 
labeled and colored red. (B) Violin Plots of key α cell identity genes compared between all α cell 
samples. Scale: Log(Normalized read counts). (C) Relative expression of select α cell genes 
along pseudo-time. Each dot represents a different cell. Scale: Relative Expression. (D) 
Analysis of top 100 branch-dependent genes determined based on clusters identified through 
pseudo-time analysis of SC-α cells, found in Table S4. Scale: Relative Expression. (E) Pseudo-
time trajectory of Stage 6, Grafted, and Human Islet α cells with branching points. (F) 
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Distribution of α cells from Grafted hESC-α (purple), Grafted hiPSC-α (pink), Stage 6 hiPSC-α 
(orange), Stage 6 hESC-α (blue), and Human Islet (red) α cells. (G) Relative expression of 
select α cell genes along SC-α cell pseudo-time. Scale: Relative Expression. See also Tables 




Figure S6. Additional characterization of SC-EC cells. Related to Figure 6. (A) Figure 4A 
with each dot representing individual sample. (B) Expression of select EC cell genes along 
pseudo-time. Each dot represents a different cell. Scale: Relative Expression. (C) Analysis of 
13 
 
top 100 branch-dependent genes determined based on clusters identified through pseudo-time 
analysis of SC-EC cells, found in Table S4. Scale: Normalized Expression. See also Table S4. 
 
